Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer
Project/Area Number |
18K15285
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 50020:Tumor diagnostics and therapeutics-related
|
Research Institution | Nagoya City University |
Principal Investigator |
Manabe Yoshihiko 名古屋市立大学, 医薬学総合研究院(医学), 研究員 (00769838)
|
Project Period (FY) |
2018-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2020: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 免疫賦活化放射線治療 / 放射線増感剤 / 抗腫瘍免疫 / 放射線増感効果 / 免疫治療 / 放射線治療 |
Outline of Final Research Achievements |
AAT-008 potentially enhances the radiosensitivity of colon cancer cells, apparently by stimulating the immune system against the cancer cells.
|
Academic Significance and Societal Importance of the Research Achievements |
放射線治療には放射線そのものによる腫瘍へのダメージと、抗腫瘍免疫活性化による効果が期待される。AAT-008は放射線治療と併用することで抗腫瘍免疫をさらに活性化させることが示唆された。この薬剤は人体への投与を前提に作成されているため実臨床応用しやすい利点がある。現在臨床で使用されている化学療法・分子標的薬・免疫チェックポイント阻害薬に加えて、新たな選択肢となる可能性がある。
|
Report
(6 results)
Research Products
(21 results)
-
[Journal Article] Biological effects of prostaglandin E2-EP4 antagonist (AAT-008) in murine colon cancer in vivo: enhancement of immune response to radiotherapy and potential as a radiosensitizer2023
Author(s)
Manabe Y, Takahashi Y, Sugie C, Wang Z, Katsuki S, Kondo T, Murai T, Nakashima M, Takaoka T, Ogawa K, Shibamoto Y
-
Journal Title
Transl Cancer Res
Volume: 12(2)
Issue: 2
Pages: 351-358
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
[Journal Article] Radiation-induced dermatitis after administration of mogamulizumab for adult T-cell leukaemia/lymphoma: a multi-institutional retrospective study.2019
Author(s)
Maemoto H, Ariga T, Kusada T, Heianna J, Manabe Y, Miyakawa A, Nakachi S, Morishima S, Iraha S, Ganaha F, Masuzaki H, Murayama S
-
Journal Title
Jpn J Clin Oncol.
Volume: 49
Issue: 2
Pages: 153-159
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-